Gene Variants Predict Breast Cancer Outcomes
Author Information
Author(s): Piersma Djura, Themmen Axel PN, Look Maxime P, Klijn Jan GM, Foekens John A, Uitterlinden André G, Pols Huibert AP, Berns Els MJJ
Primary Institution: Erasmus MC
Hypothesis
The study investigates the prognostic significance of GnRH and LHR gene variants in premenopausal breast cancer patients.
Conclusion
The LHR insLQ and GnRH 16Ser alleles are independently associated with shorter disease-free survival in premenopausal breast cancer patients.
Supporting Evidence
- Carriers of both the GnRH 16Ser and LHR insLQ alleles showed a significant increased risk of relapse.
- The study included a long follow-up period of 11 years for living patients.
- The findings suggest a potential for tailored treatment based on genetic testing.
Takeaway
Some women with specific gene variants have a higher chance of their breast cancer coming back after treatment.
Methodology
The study analyzed gene variants in 278 premenopausal breast cancer patients and compared them to 1,758 controls.
Potential Biases
Potential selection bias due to the retrospective nature of the study.
Limitations
The study is retrospective and may not account for all confounding factors.
Participant Demographics
Participants were premenopausal women with a median age of 45 years.
Statistical Information
P-Value
0.002
Confidence Interval
1.32 to 3.45
Statistical Significance
p=0.002
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website